Developing Immunologically Inert Adeno-Associated Virus (AAV) Vectors for Gene Therapy: Possibilities and Limitations

Current Pharmaceutical Biotechnology - United Arab Emirates
doi 10.2174/1389201015666140327141710
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bentham Science Publishers Ltd.

Related search

Adeno-Associated Virus Vectors for Gene Therapy, Volume 31.

American Journal of Tropical Medicine and Hygiene
MedicineVirologyParasitologyInfectious Diseases
2006English

Cancer Gene Therapy Using Adeno-Associated Virus Vectors

Frontiers in Bioscience - Landmark
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2008English

Adeno-Associated Virus Vectors

Methods in Molecular Biology
GeneticsMolecular Biology
2019English

Adeno-Associated Virus (AAV) Vector and AAV Empty Particles

Nihon Ika Daigaku Igakkai Zasshi
2017English

221. The Utilization of Capsid-Optimized Adeno-Associated Virus (AAV) Vectors for Cancer Immunotherapy

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2015English

Pre-Existing Anti–Adeno-Associated Virus Antibodies as a Challenge in AAV Gene Therapy

Human gene therapy methods
Applied MicrobiologyBiotechnologyGeneticsPharmacologyMolecular Medicine
2013English

Recombinant Adeno-Associated Virus Vectors

Japanese Journal of Thrombosis and Hemostasis
1998English

Design and Packaging of Adeno-Associated Virus Gene Targeting Vectors

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2000English

Adeno-Associated Virus-Based Gene Therapy for CNS Diseases

Human Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy